Back
46
Day Range
$73.79
$76.58
52-Week Range
$62.77
$93.50
Volume
128,303
50D / 200D Avg
$83.01
/
$80.91
Prev Close
$73.86
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 75.9 | 14.0 |
| P/B | 2.4 | 2.4 |
| ROE % | 3.1 | 11.4 |
| Net Margin % | 1.9 | 10.1 |
| Rev Growth 5Y % | 12.1 | 7.0 |
| D/E | 0.9 | 0.5 |
Key Takeaways
Revenue grew 12.07% annually over 5 years — strong growth
Earnings declined -43.08% over the past year
ROE of 3.12% is below average
Generating 60.99M in free cash flow
P/E of 75.91 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.26%
Growth
Revenue Growth (5Y)
12.07%
Revenue (1Y)16.33%
Earnings (1Y)-43.08%
FCF Growth (3Y)-8.40%
Quality
Return on Equity
3.12%
ROIC6.69%
Net Margin1.93%
Op. Margin10.30%
Safety
Debt / Equity
0.89
Current Ratio1.01
Interest Coverage8.50
Valuation
P/E Ratio
75.91
P/B Ratio2.40
EV/EBITDA19.07
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.33% | Revenue Growth (3Y) | 13.64% |
| Earnings Growth (1Y) | -43.08% | Earnings Growth (3Y) | 1.31% |
| Revenue Growth (5Y) | 12.07% | Earnings Growth (5Y) | -14.22% |
| Profitability | |||
| Revenue (TTM) | 780.99M | Net Income (TTM) | 15.06M |
| ROE | 3.12% | ROA | 1.25% |
| Gross Margin | 20.15% | Operating Margin | 10.30% |
| Net Margin | 1.93% | Free Cash Flow (TTM) | 60.99M |
| ROIC | 6.69% | FCF Growth (3Y) | -8.40% |
| Safety | |||
| Debt / Equity | 0.89 | Current Ratio | 1.01 |
| Interest Coverage | 8.50 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 75.91 | P/B Ratio | 2.40 |
| P/S Ratio | 1.46 | PEG Ratio | -3.45 |
| EV/EBITDA | 19.07 | Dividend Yield | 0.02% |
| Market Cap | 1.14B | Enterprise Value | 1.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 780.99M | 671.35M | 604.80M | 553.14M | 495.02M |
| Net Income | 15.06M | 26.46M | 14.67M | 28.27M | 27.82M |
| EPS (Diluted) | 1.42 | 1.84 | 1.28 | 3.34 | 4.49 |
| Gross Profit | 157.34M | 123.92M | 121.51M | 112.02M | 117.18M |
| Operating Income | 80.43M | 63.21M | 52.06M | 56.80M | 70.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.20B | 1.17B | 997.24M | 858.15M | 749.43M |
| Total Liabilities | 433.81M | 408.42M | 345.00M | 373.59M | 296.98M |
| Shareholders' Equity | 476.43M | 488.93M | 476.19M | 315.79M | 295.61M |
| Total Debt | 425.74M | 295.23M | 258.59M | 295.34M | 223.08M |
| Cash & Equivalents | 35.57M | 41.36M | 152.83M | 31.59M | 28.57M |
| Current Assets | 139.99M | 137.58M | 233.38M | 111.27M | 95.17M |
| Current Liabilities | 139.04M | 116.28M | 102.19M | 85.49M | 83.48M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#490 of 1018
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026